vimarsana.com

Latest Breaking News On - David bautz - Page 1 : vimarsana.com

Imunon, Inc (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc.

New jerseyUnited statesJeff churchSloan ketteringKim golodetzMichael tardugnoDavid bautzLaura surielKemp dolliverJohns hopkinsJames molloyCorinne le goffLe goffOklahoma universityIt dm clinical researchImunon inc

Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded.

Michael woodDavid bautzStacy lindborgWilliam barrJuno pharmaChaim lebovitsAdvisory committeeBrainstorm cell therapeutics incCap researchBrainstorm cell therapeuticsCall transcript novemberBrainstorm cell therapeutics third quarterCo chief executive officerAlla patlisInterim chief financialSpecial protocol assessment

MNOV: Expecting Data for MN-166 in GBM and Chlorine Gas-Induced Lung Injury – August 21, 2023 -Today at 01:21 pm

Zacks Small-Cap Research Sponsored - Impartial - Comprehensive August 21,.

South carolinaUnited statesRiverside plazaBashar al assadWanget alYanget alGorguneret alOkponyiaet alDavid bautzVan sickleet alJonassonet alBalakrishnaet alDana farber cancer instituteStrategic nationalMedicinova incResearch society on alcoholism scientific meeting

Abeona Therapeutics Inc (NASDAQ:ABEO) Q2 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Abeona Therapeutics Second Quarter 2023 Update Conference Call [Operator Instructions]. As a reminder, today s conference is being recorded.

United statesMadhav vasanthavadaKristen kluskaMaury raycroftDavid bautzBrian kevanyJames molloyJoe vazzanoAlliance global partnersCorporate communications at abeonaSociety for pediatric dermatologyIndiana universityCantor fitzgeraldAbeona therapeutics incInternational society for investigative dermatologyBusiness development

Kamada Ltd (NASDAQ:KMDA) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the Kamada Ltd. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United statesNir livnehDavid bautzChaime orlevBeit kamaBrian ritchieHydrogen groupIsraeli companies lawKamada ltdEuropean medicines agencyZacks small cap researchExchange commissionCall transcript mayFirst quarterDamir londonChief executive

vimarsana © 2020. All Rights Reserved.